$ブレインストーム セル セラピューティクス(BCLI.US)$ ⚫️BCLI's primary target is the fatal amyotrophic lateral sclerosis (ALS/MND/Lou Gehrig's). ▪️Post hoc analysis of BCLI's PIII trial data shows BCLI's NurOwn® (debamestrocel, MSC-NTF), has STATISTICALLY SIGNIFICANT clinical effects on early-stage ALS sufferers and that placebo trialists deteriorate faster. ▪️Peer reviewed research (Mar 2024) indicated that BCLI's NurOwn® has a positive impact on NfL biomarkers...
FattyChick : もしこれが2ドルを打ち出したら、私は百万長者だ。![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)